Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Caspary
S Schellong

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Hamostaseologie|August 13, 2019
R Bauersachs, S Schellong, M Stücker, et al.
Arthritis and Rheumatism|October 20, 1998
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized studyM Haubitz, S Schellong, U Göbel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 3, 2008
L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertensionJ Beyer, M Kolditz, R Ewert, et al.
The Journal of Rheumatology|April 1, 1991
Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosusL Caspary, C Schmees, I Schoetensack, et al.
VASA. Supplementum|January 1, 1989
[Association of Raynaud phenomenon with capillary morphologic changes in patients with lupus erythematosus]L Caspary, C Schmees, I Schoetensack, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Cardiac and microcirculatory effects of different doses of prostaglandin E1 in manJ H Wilkens, H Wilkens, B Elger, et al.
VASA. Supplementum|January 1, 1991
[Relation between capillary microscopy parameters and clinico-serologic data in patients with systemic lupus erythematosus]L Caspary, I Schoetensack, C Schmees, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1997
[Standardization of nailfold capillary microscopy in routine diagnosis]J A Schmidt, L Caspary, A von Bierbrauer, et al.
The Journal of Laboratory and Clinical Medicine|May 16, 2000
Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factorsC D Garlichs, J Beyer, H Zhang, et al.
Contributions to Nephrology|January 1, 1988
Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenationB Nonnast-Daniel, A Creutzig, K Kühn, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Hamostaseologie|August 13, 2019
R Bauersachs, S Schellong, M Stücker, et al.
Arthritis and Rheumatism|October 20, 1998
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized studyM Haubitz, S Schellong, U Göbel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 3, 2008
L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertensionJ Beyer, M Kolditz, R Ewert, et al.
The Journal of Rheumatology|April 1, 1991
Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosusL Caspary, C Schmees, I Schoetensack, et al.
VASA. Supplementum|January 1, 1989
[Association of Raynaud phenomenon with capillary morphologic changes in patients with lupus erythematosus]L Caspary, C Schmees, I Schoetensack, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Cardiac and microcirculatory effects of different doses of prostaglandin E1 in manJ H Wilkens, H Wilkens, B Elger, et al.
VASA. Supplementum|January 1, 1991
[Relation between capillary microscopy parameters and clinico-serologic data in patients with systemic lupus erythematosus]L Caspary, I Schoetensack, C Schmees, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1997
[Standardization of nailfold capillary microscopy in routine diagnosis]J A Schmidt, L Caspary, A von Bierbrauer, et al.
The Journal of Laboratory and Clinical Medicine|May 16, 2000
Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factorsC D Garlichs, J Beyer, H Zhang, et al.
Contributions to Nephrology|January 1, 1988
Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenationB Nonnast-Daniel, A Creutzig, K Kühn, et al.
Pageof 13